Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

HTGM


Top 10 Correlated ETFs

HTGM


Top 10 Correlated Stocks

HTGM


In the News

01:33 30 Sep 2022 HTGM

HTG Molecular Diagnostics, Inc. (HTGM) Moves to Buy: Rationale Behind the Upgrade

HTG Molecular Diagnostics, Inc. (HTGM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

08:36 30 Sep 2022 HTGM

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q2 2022 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Andrew Eriksen - LifeSci Advisors John Lubniewski - President, CEO & Director Shaun McMeans - SVP, CFO, Secretary & Treasurer Conference Call Participants Richard Miller - Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen, and welcome to the HTG Molecular Diagnostics, Inc. Second Quarter 2022 Earnings Call. [Operator Instructions].

10:49 30 Sep 2022 HTGM

Penny Stocks To Buy? 4 Short Squeeze Stocks To Watch After CPI Data

Short squeeze penny stocks to watch right now. The post Penny Stocks To Buy?

06:13 30 Sep 2022 HTGM

Check These 3 Penny Stocks Out For Your Watchlist

Which penny stocks are you watching right now? The post Check These 3 Penny Stocks Out For Your Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

12:36 30 Sep 2022 HTGM

Best Penny Stocks To Buy? 4 Low Float Stocks To Watch Now

Low float penny stocks to watch. The post Best Penny Stocks To Buy?

04:12 30 Sep 2022 HTGM

Top Penny Stocks to Buy Today? 3 to Watch Right Now

Check these three penny stocks out for your watchlist The post Top Penny Stocks to Buy Today? 3 to Watch Right Now  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

02:33 30 Sep 2022 HTGM

Best Penny Stocks to Buy Right Now? 3 to Watch in July 2022

Which penny stocks are you watching right now? The post Best Penny Stocks to Buy Right Now?

12:30 30 Sep 2022 HTGM

Best Penny Stocks For July 2022? 5 To Watch Right Now

Penny stocks to watch right now. The post Best Penny Stocks For July 2022?

04:05 30 Sep 2022 HTGM

HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

TUCSON, Ariz., May 17, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate virtually in the H.C. Wainwright Global Investment Conference being held May 23-26, 2022.

08:53 30 Sep 2022 HTGM

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2022 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - President, CEO & Director Shaun McMeans - SVP, CFO, Secretary & Treasurer Conference Call Participants Dipesh Patel - H.C. Wainwright Operator Thank you for standing by.

Financial details

Company Rating
Buy
Market Cap
6.87M
Income
-22.07M
Revenue
8.07M
Book val./share
0.51
Cash/share
1.28
Dividend
-
Dividend %
-
Employees
87
Optionable
No
Shortable
Yes
Earnings
08 Nov 2022
P/E
-0.3
Forward P/E
-
PEG
0.07
P/S
0.82
P/B
1.19
P/C
0.47
P/FCF
-0.33
Quick Ratio
1.51
Current Ratio
1.9
Debt / Equity
0.36
LT Debt / Equity
0.36
-
-
EPS (TTM)
-2.65
EPS next Y
-
EPS next Q
-
EPS this Y
-45.23%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-37.95%
Revenue last 5Y
-9.61%
Revenue Q/Q
25.93%
EPS Q/Q
-33.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
7.56%
Inst Trans
-25.54%
ROA
-99%
ROE
-210%
ROC
-1.75%
Gross Margin
-3%
Oper. Margin
-261%
Profit Margin
-273%
Payout
-
Shs Outstand
11.05M
Shs Float
9.27M
-
-
-
-
Target Price
2
52W Range
0.46-6.33
52W High
-
52W Low
-
RSI
34
Rel Volume
0.03
Avg Volume
3.51M
Volume
117.89K
Perf Week
-9.37%
Perf Month
-36.31%
Perf Quarter
-53.13%
Perf Half Y
-62.26%
-
-
-
-
Beta
1.29325
-
-
Volatility
0.01%, 0.11%
Prev Close
0%
Price
0.6
Change
-1.72%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
20.8911.727.561.851.28
Net income per share
-26.84-8.97-7.6-4.51-2.47
Operating cash flow per share
-23.46-7.18-6.57-3.52-2.38
Free cash flow per share
-24.9-7.7-7.01-3.62-2.47
Cash per share
14.1116.96136.23.16
Book value per share
-4.3311.499.443.131.5
Tangible book value per share
-4.3311.499.443.131.5
Share holders equity per share
-4.3311.499.443.131.5
Interest debt per share
14.245.774.562.872.59
Market cap
40.16M58.63M21.41M29.9M19.42M
Enterprise value
38.95M59.87M24.41M19.77M26.7M
P/E ratio
-2.12-3.56-1.11-1.43-1.13
Price to sales ratio
2.722.731.113.52.18
POCF ratio
-2.42-4.45-1.28-1.83-1.18
PFCF ratio
-2.28-4.15-1.2-1.79-1.13
P/B Ratio
-13.132.780.892.061.87
PTB ratio
-13.132.780.892.061.87
EV to sales
2.642.781.272.313
Enterprise value over EBITDA
-2.37-4.25-1.47-1.07-1.74
EV to operating cash flow
-2.35-4.54-1.46-1.21-1.62
EV to free cash flow
-2.21-4.24-1.37-1.18-1.56
Earnings yield
-0.47-0.28-0.9-0.7-0.88
Free cash flow yield
-0.44-0.24-0.83-0.56-0.88
Debt to equity
-0.970.460.290.590.59
Debt to assets
1.140.520.470.590.66
Net debt to EBITDA
0.07-0.09-0.180.55-0.47
Current ratio
1.355.424.654.542.73
Interest coverage
-13.55-17.92-19.8-19.11-16.74
Income quality
0.870.80.870.780.96
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.190.930.972.110
Research and developement to revenue
0.680.590.550.710.68
Intangibles to total assets
00000
Capex to operating cash flow
0.060.070.070.030.04
Capex to revenue
-0.07-0.04-0.06-0.05-0.07
Capex to depreciation
-0.82-0.65-0.64-0.34-0.89
Stock based compensation to revenue
0.10.090.060.210.15
Graham number
51.1448.1640.1617.829.13
ROIC
-2.24-0.44-0.52-0.7-0.87
Return on tangible assets
-0.89-0.38-0.43-0.59-0.56
Graham Net
-12.7275.862.140.64
Working capital
4.61M30.98M32.47M25.63M17.24M
Tangible asset value
00000
Net current asset value
-6.37M15.32M20.22M12.16M7.13M
Invested capital
-2.860.460.440.851.62
Average receivables
3.97M3.3M2.38M1.59M1.84M
Average payables
1.89M1.6M1.51M1.35M1.5M
Average inventory
1.34M1.4M1.38M1.49M1.74M
Days sales outstanding
157.1985.0860.1467.8385.75
Days payables outstanding
179.04132.6468.1123.3473.51
Days of inventory on hand
86.6793.6952136.4588.59
Receivables turnover
2.324.296.075.384.26
Payables turnover
2.042.755.362.964.97
Inventory turnover
4.213.97.022.684.12
ROE
6.2-0.78-0.81-1.44-1.65
Capex per share
-1.44-0.52-0.43-0.1-0.09

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
0.310.340.390.150.14
Net income per share
-0.39-0.6-0.7-0.81-0.54
Operating cash flow per share
-0.68-0.57-0.46-0.74-0.53
Free cash flow per share
-0.7-0.61-0.46-0.74-0.53
Cash per share
4.453.422.952.691.28
Book value per share
2.7621.41.410.51
Tangible book value per share
2.7621.41.410.51
Share holders equity per share
2.7621.41.410.51
Interest debt per share
1.671.642.31.210.85
Market cap
38.85M42.48M40.33M11.14M11.33M
Enterprise value
36.17M44.2M47.6M5.99M14.64M
P/E ratio
-3.71-2.37-1.94-0.43-0.48
Price to sales ratio
18.7316.8614.029.47.6
POCF ratio
-8.54-10.08-11.9-1.87-1.94
PFCF ratio
-8.28-9.31-11.71-1.87-1.94
P/B Ratio
2.112.853.880.992.03
PTB ratio
2.112.853.880.992.03
EV to sales
17.4417.5416.555.069.82
Enterprise value over EBITDA
-16.74-10.97-9.89-0.99-2.49
EV to operating cash flow
-7.95-10.48-14.04-1.01-2.5
EV to free cash flow
-7.71-9.68-13.82-1.01-2.5
Earnings yield
-0.07-0.11-0.13-0.58-0.52
Free cash flow yield
-0.12-0.11-0.09-0.53-0.52
Debt to equity
0.40.490.590.360.36
Debt to assets
0.510.570.660.60.75
Net debt to EBITDA
1.24-0.43-1.510.85-0.56
Current ratio
5.033.932.732.991.9
Interest coverage
-15.68-15.87-18.44-25.09-23.8
Income quality
1.740.940.650.910.99
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.620.610.661.621.24
Intangibles to total assets
00000
Capex to operating cash flow
0.030.080.0200
Capex to revenue
-0.07-0.14-0.02-0.010
Capex to depreciation
-0.81-1.81-0.35-0.05-0.04
Stock based compensation to revenue
0.170.130.10.230.13
Graham number
4.935.214.685.072.47
ROIC
-0.14-0.16-0.24-0.31-0.47
Return on tangible assets
-0.07-0.13-0.17-0.23-0.27
Graham Net
1.961.130.60.74-0.06
Working capital
28.8M23.66M17.24M16.92M9.17M
Tangible asset value
00000
Net current asset value
17.07M12.13M7.13M8.22M2.69M
Invested capital
0.590.81.620.841.63
Average receivables
1.09M1.33M1.42M749.22K1M
Average payables
1.5M1.23M1.48M1.32M1.22M
Average inventory
2.17M2.18M2.01M2.02M1.99M
Days sales outstanding
61.6968.0165.4656.9375.97
Days payables outstanding
155.92104.8327.24138.6299.31
Days of inventory on hand
214.85214.1532.83212.88173.52
Receivables turnover
1.461.321.371.581.18
Payables turnover
0.580.863.30.650.91
Inventory turnover
0.420.422.740.420.52
ROE
-0.14-0.3-0.5-0.58-1.06
Capex per share
-0.02-0.05-0.0100

Frequently Asked Questions

What is HTG Molecular Diagnostics, Inc. stock symbol ?

HTG Molecular Diagnostics, Inc. is a US stock , located in Tucson of Arizona and trading under the symbol HTGM

Is HTG Molecular Diagnostics, Inc. buy or a sell ?

2 stock analysts have 2 predictions with a medium analyst target price of $2.5. The lowest prediction is $2 and the highest is $3

What is HTGM stock prediction ?

With a median analyst target price of $2, 1 stock analysts have made 1 forecasts in last 90 days. $2 is the lowest and $2 is the greatest projection.

What is HTG Molecular Diagnostics, Inc. stock quote today ?

HTG Molecular Diagnostics, Inc. stock price is $0.6 today.

Is HTG Molecular Diagnostics, Inc. stock public?

Yes, HTG Molecular Diagnostics, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap